article

1. Anticoagulant therapy in renal insufficiency theme: Anticoagulation in complex situations..  Thrombosis research.  -. 2024
2. Use of patient-reported outcome measures in patients with venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease..  Journal of thrombosis and haemostasis : JTH.  21:2953-2962. 2023
3. Blood Clots, or Thrombosis, in Patients With Cancer..  JAMA oncology.  9:-. 2023
4. Periprocedural Anticoagulation..  Annals of internal medicine.  176:ITC49-ITC64. 2023
5. Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19..  JAMA network open.  6:-. 2023
6. Teaching a Deeper Understanding of the Medical Literature..  Journal of general internal medicine.  38:1059-1060. 2022
7. Health-related quality of life associated with warfarin and direct oral anticoagulants in venous thromboembolism..  Thrombosis research.  97-102. 2022
8. What Can At-home Genetic Tests Tell Me About My Health?.  JAMA internal medicine.  182:-. 2022
9. Venous thromboembolism (VTE) prevention and diagnosis in COVID-19: Practice patterns and outcomes at 33 hospitals..  PloS one.  17:-. 2022
10. Long-term functional outcomes and mortality after hospitalization for extracranial hemorrhage..  Journal of hospital medicine.  17:235-242. 2022
11. Persistent Gender Pay Gaps in Medicine: What Is Good for the Goose Is Better for the Gander's Paycheck..  JAMA internal medicine.  181:-. 2021
12. Anticoagulation at the End of Life: Time for a Rational Framework..  JAMA internal medicine.  181:-. 2021
13. An Elusive Seizure..  The Neurohospitalist.  12:188-194. 2021
14. Long-term individual and population functional outcomes in older adults with atrial fibrillation..  Journal of the American Geriatrics Society.  69:1570-1578. 2021
15. Incidence, management and outcomes of arterial and venous thrombosis after chimeric antigen receptor modified T cells for B cell lymphoma and multiple myeloma..  Leukemia & lymphoma.  62:1003-1006. 2020
16. Long-term individual and population functional outcomes in older adults with atrial fibrillation..  medRxiv : the preprint server for health sciences.  2020
17. Succeeding in Aging Research During the Pandemic: Strategies for Fellows and Junior Faculty..  Journal of the American Geriatrics Society.  69:8-11. 2020
18. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic..  Thrombosis research.  355-358. 2020
19. Refining Risk for Deep Vein Thrombosis in Hospitalized Patients..  Journal of general internal medicine.  33:-. 2018
20. Dabigatran Compared With Rivaroxaban vs Warfarin-Reply..  JAMA internal medicine.  177:-. 2017
21. Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding..  Seminars in thrombosis and hemostasis.  43:514-524. 2017
22. Applying Academic Detailing and Process Change to Promote Choosing Wisely-Reply..  JAMA internal medicine.  177:-. 2017
23. Women in Medicine and Patient Outcomes: Equal Rights for Better Work?.  JAMA internal medicine.  177:-. 2017
24. Comparing Non-Vitamin K Oral Anticoagulants: Where We Are Now..  JAMA internal medicine.  176:-. 2016
25. From Choosing Wisely to Practicing Value-More to the Story..  JAMA internal medicine.  176:1571-1572. 2016
26. Anticoagulation in the Very Old..  JAMA internal medicine.  176:-. 2016
27. Anticoagulation in Older Adults with Multimorbidity..  Clinics in geriatric medicine.  32:331-46. 2016
28. Teaching High-Value Care on Rounds: Modeling Moderation..  JAMA internal medicine.  176:262-3. 2016
29. Cases of spontaneous tumor regression in hepatobiliary cancers: implications for immunotherapy?.  Journal of gastrointestinal cancer.  46:161-5. 2015
30. Male obesity and alteration in sperm parameters..  Fertility and sterility.  90:2222-5. 2008